Vimarsana
Biggest News Aggregation in the World

Avanzanite Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Avanzanite Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Avanzanite Bioscience Today - Breaking & Trending Today

Avanzanite Bioscience Expands Partnership With Advicenne in Additional European Countries - Vimarsana News

Avanzanite Bioscience Expands Partnership With Advicenne in Additional European Countries

AMSTERDAM, October 18, 2023--Avanzanite's expanded collaboration with Advicenne now includes Ireland, Cyprus and Malta in addition to existing markets (DE, AT, CH, GR, LI).

Source: yahoo.com
Avanzanite Bioscience Further Strengthens Leadership Team With Country Manager of Germany - Vimarsana News

Avanzanite Bioscience Further Strengthens Leadership Team With Country Manager of Germany

AMSTERDAM--(BUSINESS WIRE)--Sep 19, 2023--

Advicenne Reports its First Half Financial Results as of June 30, 2023 and Updates on Its Activities - Vimarsana News

Advicenne Reports its First Half Financial Results as of June 30, 2023 and Updates on Its Activities

51% increase in Sibnayal® gross sales to €0.96 millionSignificant reduction in operating losses to €2.9 million (vs. €4.4 million in H1 2022)€0.9 million improvement in cash flow from operationsCash position of €3.42 millionCompletion of European marketing coverage for Sibnayal®Launch of a capital increase with pref...

Avanzanite Bioscience B.V.: Avanzanite Bioscience Partners With Advicenne to Commercialize Sibnayal For the Treatment of Rare Kidney Disease in Germany, Austria, Switzerland and Greece - Vimarsana News

Avanzanite Bioscience B.V.: Avanzanite Bioscience Partners With Advicenne to Commercialize Sibnayal For the Treatment of Rare Kidney Disease in Germany, Austria, Switzerland and Greece

Advicenne agreement further validates Avanzanite's unique business model and establishes it as the go-to commercialization partner for medicines treating rare diseases across Europe Avanzanite

Avanzanite Bioscience Partners With Advicenne to Commercialize Sibnayal® For the Treatment of Rare Kidney Disease in Germany, Austria, Switzerland and - Vimarsana News

Avanzanite Bioscience Partners With Advicenne to Commercialize Sibnayal® For the Treatment of Rare Kidney Disease in Germany, Austria, Switzerland and

Advicenne agreement further validates Avanzanite’s unique business model and establishes it as the go-to commercialization partner for medicines treating rare diseases across EuropeAvanzanite now transitioning to sales execution with the first anticipated commercial launch in Germany mid 2023 AMSTERDAM--(...